The method employs ultrathin membranes to capture small packets of cellular material known as extracellular vesicles. Cells ...

The data contain efficacy results and correlative outcomes with biomarkers based on a median follow-up of ... ATORX), a ...

Join us this National Cancer Awareness Day to deepen your understanding of clinical trials for cancer. Discover their ...

The ROS-1 NSCLC current market is mainly dominated by tyrosine kinase inhibitors such as XALKORI at present and is ...

BioMark Strengthens Liquid Biopsy Platform for Breast Cancer Detection. Vancouver, British Columbia--(Newsfile Corp. - November 5, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE ...

Pre-orders now available; early access available for select strategic partners for the PhenoCode IO60 panel – The Fastest Ultrahigh-plex Panel ...

People with FSHD, ages 16 to 70, enrolled in this Phase 1/2 FORTITUDE trial cohort will aid biomarker data to support early approval request.

Purple Biotech (PPBT) has released an update. Purple Biotech has identified a new serum biomarker, CEACAM1, which may ...

A new immune cell biomarker has been discovered that can predict the effectiveness of immune anticancer treatment in patients ...